160 related articles for article (PubMed ID: 35789244)
1. Membranoproliferative glomerulonephritis: current histopathological classification, clinical profile, and kidney outcomes.
Bernardes TP; Mastroianni-Kirsztajn G
J Bras Nefrol; 2023; 45(1):45-50. PubMed ID: 35789244
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of membranoproliferative glomerulonephritis based on a new classification at a single center.
Nakano M; Karasawa K; Moriyama T; Uchida K; Nitta K
Clin Exp Nephrol; 2019 Jun; 23(6):852-858. PubMed ID: 30854618
[TBL] [Abstract][Full Text] [Related]
3. Recurrence of immune complex and complement-mediated membranoproliferative glomerulonephritis in kidney transplantation.
Caravaca-Fontán F; Polanco N; Villacorta B; Buxeda A; Coca A; Ávila A; Martínez-Gallardo R; Galeano C; Valero R; Ramos N; Allende N; Cruzado-Vega L; Pérez-Sáez MJ; Sevillano Á; González E; Hernández A; Rodrigo E; Fernández-Ruiz M; Aguado JM; Pérez Valdivia MÁ; Pascuall J; Andrés A; Praga M;
Nephrol Dial Transplant; 2023 Jan; 38(1):222-235. PubMed ID: 35404425
[TBL] [Abstract][Full Text] [Related]
4. [Familial membranoproliferative glomerulonephritis].
Bogdanović RM; Dimitrjević JZ; Nikolić VN; Ognjanović MV; Rodić BD; Slavković BV
Srp Arh Celok Lek; 1999; 127(5-6):163-71. PubMed ID: 10500423
[TBL] [Abstract][Full Text] [Related]
5. Comparison of laboratory findings in patients with glomerulonephritis classified according to histopathologic diagnosis.
Kirac Y; Bilen S; Duranay M
Minerva Med; 2014 Apr; 105(2):149-56. PubMed ID: 24727879
[TBL] [Abstract][Full Text] [Related]
6. Morphofunctional Effects of C5 Convertase Blockade in Immune Complex-Mediated Membranoproliferative Glomerulonephritis: Report of Two Cases with Evidence of Terminal Complement Activation.
Carrara C; Podestà MA; Abbate M; Rizzo P; Piras R; Alberti M; Daina E; Ruggenenti P; Remuzzi G;
Nephron; 2020; 144(4):195-203. PubMed ID: 32050203
[TBL] [Abstract][Full Text] [Related]
7. C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical Trial.
Ruggenenti P; Daina E; Gennarini A; Carrara C; Gamba S; Noris M; Rubis N; Peraro F; Gaspari F; Pasini A; Rigotti A; Lerchner RM; Santoro D; Pisani A; Pasi A; Remuzzi G;
Am J Kidney Dis; 2019 Aug; 74(2):224-238. PubMed ID: 30929851
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and Prognostic Comparison of Immune-Complex-Mediated Membranoproliferative Glomerulonephritis and C3 Glomerulopathy.
Kovala M; Seppälä M; Räisänen-Sokolowski A; Meri S; Honkanen E; Kaartinen K
Cells; 2023 Feb; 12(5):. PubMed ID: 36899849
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features of membranoproliferative glomerulonephritis under a new classification.
Nargund P; Kambham N; Mehta K; Lafayette RA
Clin Nephrol; 2015 Dec; 84(6):323-30. PubMed ID: 26445002
[TBL] [Abstract][Full Text] [Related]
10. Long-term clinical and morphological evaluation of primary membranoproliferative glomerulonephritis.
Wu MJ; Shu KH; Chan LP; Lu YS; Cheng CH; Sheu SS; Hsu YH; Lian JD
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jan; 57(1):34-41. PubMed ID: 8820034
[TBL] [Abstract][Full Text] [Related]
11. Membranoproliferative glomerulonephritis and circulating cryoglobulins.
Hiramatsu R; Hoshino J; Suwabe T; Sumida K; Hasegawa E; Yamanouchi M; Hayami N; Sawa N; Takaichi K; Ohashi K; Fujii T; Ubara Y
Clin Exp Nephrol; 2014 Feb; 18(1):88-94. PubMed ID: 23722669
[TBL] [Abstract][Full Text] [Related]
12. Membranoproliferative glomerulonephritis: no longer the same disease and may need very different treatment.
Noris M; Daina E; Remuzzi G
Nephrol Dial Transplant; 2023 Feb; 38(2):283-290. PubMed ID: 34596686
[TBL] [Abstract][Full Text] [Related]
13. Renal Pathologic Findings in TAFRO Syndrome: Is There a Continuum Between Thrombotic Microangiopathy and Membranoproliferative Glomerulonephritis? A Case Report and Literature Review.
Leurs A; Gnemmi V; Lionet A; Renaud L; Gibier JB; Copin MC; Hachulla E; Hatron PY; Launay D; Fajgenbaum D; Terriou L
Front Immunol; 2019; 10():1489. PubMed ID: 31316523
[No Abstract] [Full Text] [Related]
14. Glomerular paramesangial deposits: association with hypocomplementemia in membranoproliferative glomerulonephritis types I and III.
West CD; McAdams AJ
Am J Kidney Dis; 1998 Mar; 31(3):427-34. PubMed ID: 9506679
[TBL] [Abstract][Full Text] [Related]
15. Manifestations of Complement-Mediated and Immune Complex-Mediated Membranoproliferative Glomerulonephritis: A Comparative Consecutive Series.
Dalvin LA; Fervenza FC; Sethi S; Pulido JS
Ophthalmology; 2016 Jul; 123(7):1588-94. PubMed ID: 26996341
[TBL] [Abstract][Full Text] [Related]
16. Hypocomplementemic urticarial vasculitis syndrome with gastrointestinal vasculitis and crescentic membranoproliferative glomerulonephritis without immune complex deposits.
Ueki K; Tsuchimoto A; Matsukuma Y; Torisu K; Fujisaki K; Torisu T; Yamada Y; Oda Y; Masutani K; Nakano T; Tsuruya K; Kitazono T
CEN Case Rep; 2020 Feb; 9(1):30-35. PubMed ID: 31586313
[TBL] [Abstract][Full Text] [Related]
17. Demographic, clinical characteristics and treatment outcomes of immune-complex membranoproliferative glomerulonephritis and C3 glomerulonephritis in Japan: A retrospective analysis of data from the Japan Renal Biopsy Registry.
Nakagawa N; Mizuno M; Kato S; Maruyama S; Sato H; Nakaya I; Sugiyama H; Fujimoto S; Miura K; Matsumura C; Gotoh Y; Suzuki H; Kuroki A; Yoshino A; Nakatani S; Hiromura K; Yamamoto R; Yokoyama H; Narita I; Isaka Y
PLoS One; 2021; 16(9):e0257397. PubMed ID: 34520493
[TBL] [Abstract][Full Text] [Related]
18. Positive C1q staining associated with poor renal outcome in membranoproliferative glomerulonephritis.
Takei T; Itabashi M; Moriyama T; Shimizu A; Tsuruta Y; Ochi A; Nakayama K; Iwasaki C; Uchida K; Nitta K
Clin Exp Nephrol; 2013 Feb; 17(1):92-8. PubMed ID: 22821391
[TBL] [Abstract][Full Text] [Related]
19. [The course and prognosis of mesangioproliferative glomerulonephritis].
Shilov EM; Tareeva IE; Ivanov AA; Troepol'skaia OV; Krasnova TN; Varshavskiĭ VA; Proskurneva EP; Ivanova LV; Khudova IIu; Miroshnichenko NG
Ter Arkh; 2002; 74(6):11-8. PubMed ID: 12136475
[TBL] [Abstract][Full Text] [Related]
20. Histopathology of MPGN and C3 glomerulopathies.
Cook HT; Pickering MC
Nat Rev Nephrol; 2015 Jan; 11(1):14-22. PubMed ID: 25447133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
